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The Pathophysiology of Athlete’s Heart
Hannah McKee, BSN, RN
Otterbein University, Westerville, Ohio
What is Athlete’s Heart?
Athlete’s heart is a pathologic cardiac
hypertrophy, closely resembling
hypertrophic cardiomyopathy (HCM),
seen in those who undergo regular,
intense exercise (Pagourelias et al.,
2014). Per Pagourelias et al., (2014),
athlete’s heart is characterized by two
main findings on echocardiography:
• Left ventricular hypertrophy
(LVH)
• Intraventricular septum
thickness (IVST)
Other findings may be present in some
cases, but are not necessary for
diagnosis:
•
Left atrial dilation and dysfunction
(Gabrielli et al., 2012)
•
Enlarged right and left ventricles
(O’Keefe et al., 2012)
These findings take time to occur, taking
roughly two years of vigorous exercise
for at least five hours per week to cause
the changes seen with athlete’s heart
(Martinez & Nair, 2014). These
adaptations occur so that the heart can
more readily meet the body’s demand.
The author first saw this phenomenon
on an echocardiogram (echo) of a 17year-old female patient. The patient
came into the cardiologist’s office with
complaints of near syncope and
dizziness. The patient was a high school
athlete who played sports year-round
and was on her high school basketball,
cross-country, and track teams. The
patient exercised vigorously for over 2-3
hours per day for the past 3 years. Her
echo showed LVH, IVST and some left
atrial dilation. The patient was
bradycardic with an ejection fraction
(EF) in the high normal range. The
author became interested in
understanding the pathophysiology of
how the heart developed these
functional changes and how they affect
the athlete in both the short and long
terms.

Athlete’s heart is the result of
reversible physiological
remodeling resulting in increased
cardiac mass, but normal cardiac
function (Weeks & McMullen,
2011). There are slight
differences in the extent of
remodeling present based on type
of exercise:
• In endurance athletes, such
as runners and swimmers,
the left ventricle’s walls
thicken and left ventricle
dilates.
• In strength athletes, such
as weightlifters and
wrestlers, the left
ventricle’s walls thicken
and only mild ventricular
dilation is present.
• In combination exercise,
exhibited by rowers,
cyclists and canoeists, the
left ventricular walls are
grossly thickened and left
dilation is present (Weeks
& McMullen, 2011).
There are two types of athlete’s
heart. These types are
differentiated based on the
pathologic changes seen in the
heart anatomy:
• Eccentric myocardial
hypertrophy due to volume
overload
• Concentric hypertrophy
due to resistance load
(Galanti, Stefani,
Mascherini, Di Tante, &
Toncelli, 2016).

The eccentric form is defined by the
presence of left ventricular wall
thickness and left ventricular dilation
(Galanti et al., 2016). Left
ventricular wall thickness is present
in the concentric form, but no left
ventricular dilation is seen (Galanti
et al., 2016). The eccentric form is
more commonly seen in endurance
athletes, while the concentric form is
seen more in strength trainers
(Weeks & McMullen, 2011).
Cardiac formation of insulin-like
growth factor 1 (IFG1) plays a large
role in stimulating the physiologic
changes necessary for the
development of athlete’s heart
(Weeks & McMullen, 2011). When
IGF1 levels are elevated, the heart
has the ability to increase in size due
to intense exercise (Weeks &
McMullen, 2011). Elevated IGF1
leads to the overexpression of IGF1
receptor (IGF1R) triggering
downstream signaling of
phosphoinositide 3-kinase p110α
[PI3K(p110α)] and protein kinase B
(Akt1) activation (Weeks &
McMullen, 2011). PI3K(p110α) uses
plasma membrane lipids to form
phosphatidylinositol 3,4,5triphosphate (PIP3) (Weeks &
McMullen, 2011). PIP3 is a second
messenger used to activate Akt
(Weeks & McMullen, 2011). Akt,
particularly the Akt1 isoform of Akt,
affects protein synthesis and
apoptosis, allowing cardiac
remodeling to occur (Weeks &
McMullen, 2011).

Signs & Symptoms
Most athletes are asymptomatic
(McKelvie, 2017). However, according
to McKelvie (2017), a variety of signs
may be present:
• Bradycardia
• Left ventricular impulse that is
out of place, large, and with
increased amplitude
• Systolic flow murmur
• S3 and S4 heart sounds
• Hyperdynamic carotid pulses

Implications for
Nursing Care

Underlying Pathophysiology

Figure 1. Echocardiographic difference between the thickness of the
intraventricular septum of a normal heart versus that of one with
pathophysiologic athlete’s heart.
Image retrieved from http://medifitbiologicals.com/athletes-heart/

Figure 2. A comparison of the anatomy of the normal heart, the athlete’s heart and the heart
with hypertrophic cardiomyopathy.
Image retrieved from
http://www.imgrum.org/user/doctordconline/1591812152/952597801020270435_1591812152

Significance of Pathophysiology
The diagnosis of athlete’s heart is typically
done through clinical evaluation, EKG, echo,
and, rarely, stress testing (McKelvie, 2017).
On EKG, the patient may exhibit various
arrhythmias:
• Sinus arrhythmia
• Sinus bradycardia at rest that can lead to
atrial tachycardia, non-sustained
ventricular tachycardia, or premature
ventricular contractions
• Atrioventricular (AV) blocks
▪ 1st degree AV block is most common
▪ 2nd degree type 1 AV block that is
present at rest and disappears with
exercise
▪ Rarely 3rd degree AV block
• High-voltage QRS with inferolateral Twave changes that show LVH on the EKG
• Deep anterolateral T-wave inversion
• Incomplete right bundle branch block
(RBBB) (McKelvie, 2017)
Echocardiography is an important imaging
modality in the diagnosis and assessment. An
echo can show:
• Left ventricular septal thickness
between 13-15 mm in men and 11-13
mm in women (McKelvie, 2017)
• Left ventricular mass seen as LVH
• Left ventricular dilation (McDiarmid et
al., 2016)

The twisting methods of apical rotation
(Arot) and apical circumference left ventricular
strain (AVCS) support the increased
cardiovascular performance seen on an echo in
athlete’s heart during maximal intensity
exercise (Santoro et al., 2015). During
exercise, the left ventricular end-diastolic
volume decreases and subpericardial fibers
have a mechanical advantage, allowing the left
ventricle to eject a greater volume of blood
during systole (Santoro et al., 2015). Reduced
end-diastolic volume paired with increased
heart rate during exercise is thought to cause
myofiber alignment to change in a manner that
increases left ventricular twisting, making it
more effective (Santoro et al., 2015). In
athlete’s heart, the torsional reserve is an
important factor in the systolic-diastolic
coupling seen during high-intensity exercise,
improving stroke volume (Santoro et al., 2015).
While stress testing is rarely used to
diagnose athlete’s heart, it can be used to help
distinguish physiologic changes from
pathologic diseases (McKelvie, 2017). Stress
testing shows:
• Submaximal heart rate response to
maximal stress with a normal blood
pressure response
• Resting EKG abnormalities may
disappear with exercise (McKelvie,
2017).

It is important for the provider to
distinguish athlete’s heart from the pathologic
remodeling seen with hypertrophic
cardiomyopathy (HCM). HCM can result in
sports-related sudden cardiac death (SCD),
making distinguishability vital to proper
patient care (Pagourelias et al., 2014).
Several different factors are used to
distinguish between HCM and athlete’s heart:
• Left ventricular end-diastolic diameter
• Relative wall thickness
• Deceleration time
• Isovolumic relaxation time
• Tricuspid E/A
• Septal E’
• QRS-T angle
• Brain natriuretic peptides (Pagourelias
et al., 2014)
A relative septal thickness of greater than
0.54 and spatial QRS-T angle of greater than
45 were found to be most useful in the
diagnosis of HCM in studies that looked at
both the patient’s echo and EKG to distinguish
between the two conditions (Pagourelias et
al., 2014).
Athlete’s heart is traditionally considered
reversible condition. New studies are
beginning to show that elite athletes who
undergo chronic high-intensity, high
endurance exercise training may exhibit
cardiac remodeling that is not completely
benign (O’Keefe et al., 2012). Studies of
retired athletes show that even years into
retirement, the heart does not completely
regress to normal physiology (O’Keefe et al.,
2012). The most evident changes found
during exercise are:
• Acute dilation of the right atrium
• Acute dilation of the right ventricle
• Sudden decrease in right ventricular
EF
• Elevated troponin and B-type
natriuretic peptides
• Myocardial fibrosis
• Aortic valve stiffness
• Higher than expected levels of
coronary artery calcium and calcified
coronary plaque volume
Elite endurance athletes have a higher
prevalence of atrial fibrillation, which is likely
due to a variety of mechanisms (O’Keefe et al.,
2012). Athletes exhibit increased vagal and
sympathetic tones, bradycardia, inflammatory
changes, myocardial fibrosis, and atrial
dilation (O’Keefe et al., 2012). It’s possible
that left atrial dilation could predict the
likelihood of developing atrial fibrillation,
however this is all still under investigation
(O’Keefe et al., 2012).

Conclusion
Athlete’s heart is the result of longterm high-intensity exercise causing
physiologic hypertrophy of the heart
(Weeks & McMullen, 2011). The heart
adapts to the increases in demand
needed for high-intensity, highendurance exercise by increasing in size,
resulting in hypertrophy of the left
ventricle and intraventricular septum
(Pagourelias et al., 2014). Differentiating
between athlete’s heart and HCM is
important as they are treated quite
differently since HCM can result in SCD
(Pagourelias et al., 2014). While athlete’s
heart is considered a reversible
condition, new research shows that in
career athletes the heart may never
return to normal cardiovascular function
(O’Keefe et al., 2012). The provider
needs to be aware of the pathophysiology
of athlete’s heart and its long-term
effects on the cardiovascular system in
order to care for athletic patients
effectively.
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